Biotech Values

[drbio45]

Ipsen gets FDA nod for Somatuline Autogel product


headline from reuters....don't they realize that accepting a filing is not the same as giving its nod to a drug. The person that allows these headlines should be fired


Mon Jan 15, 2007 2:15am ET
Market View
IPN (Ipsen )
Last: €36.01
Change: +0.91 (+2.59%)
Revenue (ttm): M
EPS:
Market Cap: M
Time: 10:41am ET



Stock Details
Company Profile
Analyst Research Email This Article | Print This Article | Reprints [-] Text [+]
PARIS, Jan 15 (Reuters) - French biotechnology group Ipsen (IPN.PA: Quote, Profile , Research) said on Monday that the U.S. Food & Drug Administration (FDA) had accepted the filing of a new drug application for its Somatuline Autogel product.

Somatuline Autogel is used to treat a symptom called acromegaly, which is a disorder caused by the overproduction of growth hormones secondary to a benign tumour of the anterior pituitary gland.

The product has already had marketing approval in over 50 countries.


Reuters Pictures

Editors Choice: Best pictures
from the last 24 hours.
View Slideshow

© Reuters 2007. All Rights Reserved.